Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1

被引:45
作者
Ataga, Kenneth I. [1 ,2 ]
Brittain, Julia E. [2 ,3 ]
Moore, Dominic [4 ]
Jones, Susan K. [1 ,2 ]
Hulkower, Ben [2 ]
Strayhorn, Dell [1 ,2 ]
Adam, Soheir [1 ,2 ]
Redding-Lallinger, Rupa [2 ,5 ]
Nachman, Patrick [6 ]
Orringer, Eugene P. [1 ,2 ]
机构
[1] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Comprehens Sickle Cell Program, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC 27599 USA
关键词
hemophilia A; mutations; structure-function; factor VIII; GROWTH-FACTOR RECEPTOR; 3RD NATIONAL-HEALTH; RISK-FACTORS; RENAL-FUNCTION; CHILDREN; MICROALBUMINURIA; ADULTS; PREVALENCE; FAILURE; ANEMIA;
D O I
10.1111/j.1600-0609.2010.01471.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hemophilia A (HA) is a common X-linked recessive bleeding disease caused by mutations in FVIII gene. The identification of mutation in HA subjects can lead to more accurate diagnosis and contribute to the genetic counseling/prenatal diagnosis. Objectives: Our objective is to identify the FVIII defects in 148 unrelated Chinese HA subjects and to analyze the potential consequence of novel mutations. Methods: FVIII: C was assayed using one-stage method, and FVIII inhibitor was tested using Bethesda method. Intron 22 and 1 inversions were identified by PCR technique. Non-inversion mutations of FVIII gene were identified by direct sequencing. Novel mutations were further analyzed based on a B-domain deleted FVIII crystallographic structure and bioinformatics tools. Results: The intron 22 and 1 inversions affected 57 and three severe subjects, respectively. Sixty-seven different mutations were identified in non-inversion subjects including 35 novel mutations that were not reported previously. Novel mutations include five nonsense mutations, 15 missense mutations, three insertions, eight small deletions, two splice site mutations and two partial gene deletions. The potential deleterious effects of these novel missense mutations include disruption of the protein core, impairment of inter-domain interaction and FVIII binding with other proteins. Conclusion: Similar to other races, intron 22 and one inversions are also recurrent mutation in severe HA subjects monitored in our centre. Sixty-seven mutations (52% novel reported) among 88 non-inversion subjects represent the high degree of heterogeneity of FVIII gene mutations causing HA. Characteristic of HA FVIII gene mutations extend our insight into structure-function relationship of the FVIII molecule.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 38 条
  • [1] Early blood transfusions protect against microalbuminuria in children with sickle cell disease
    Alvarez, Ofelia
    Montane, Brenda
    Lopez, Gabriela
    Wilkinson, James
    Miller, Tracie
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 47 (01) : 71 - 76
  • [2] Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study
    Anwaruddin, S
    Lloyd-Jones, DM
    Baggish, A
    Chen, A
    Krauser, D
    Tung, R
    Chae, C
    Januzzi, JL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 91 - 97
  • [3] Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
    Aslan, M
    Ryan, TM
    Adler, B
    Townes, TM
    Parks, DA
    Thompson, JA
    Tousson, A
    Gladwin, MT
    Patel, RP
    Tarpey, MM
    Batinic-Haberle, I
    White, CR
    Freeman, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) : 15215 - 15220
  • [4] Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994)
    Astor, BC
    Muntner, P
    Levin, A
    Eustace, JA
    Coresh, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) : 1401 - 1408
  • [5] Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
    Ataga, Kenneth, I
    Moore, Charity G.
    Hillery, Cheryl A.
    Jones, Susan
    Whinna, Herbert C.
    Strayhorn, Dell
    Sohier, Cathy
    Hinderliter, Alan
    Parise, Leslie, V
    Orringer, Eugene P.
    [J]. HAEMATOLOGICA, 2007, 93 (01) : 20 - 26
  • [6] Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
    Ataga, Kenneth I.
    Moore, Charity G.
    Jones, Susan
    Olajide, Oludamilola
    Strayhorn, Dell
    Hinderliter, Alan
    Orringer, Eugene P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (01) : 109 - 115
  • [7] ATAGA KI, 2010, ANN NAT SICKL CELL D
  • [8] Placenta growth factor in sickle cell disease: association with hemolysis and inflammation
    Brittain, Julia E.
    Hulkower, Ben
    Jones, Susan K.
    Strayhorn, Dell
    De Castro, Laura
    Telen, Marilyn J.
    Orringer, Eugene P.
    Hinderliter, Alan
    Ataga, Kenneth I.
    [J]. BLOOD, 2010, 115 (10) : 2014 - 2020
  • [9] Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
    Castro, O
    Hoque, M
    Brown, BD
    [J]. BLOOD, 2003, 101 (04) : 1257 - 1261
  • [10] Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes
    De Castro, Laura M.
    Jonassaint, Jude C.
    Graham, Felicia L.
    Ashley-Koch, Allison
    Telen, Marilyn J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (01) : 19 - 25